financetom
Business
financetom
/
Business
/
Onyx Gold Closes $8-Million Financing and Increases Non-Brokered Offering with Strategic Investors
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Onyx Gold Closes $8-Million Financing and Increases Non-Brokered Offering with Strategic Investors
May 26, 2025 12:45 PM

01:00 PM EDT, 05/22/2025 (MT Newswires) -- Onyx Gold ( ONXGF ) on Thursday it closed an $8-million bought-deal private placement of flow-through shares.

The offering included 5-million Tranche 1 flow-through shares at a price of $1.00 each for aggregate gross proceeds of $5 million and 3.1-million Tranche 2 flow-through shares at a price of $0.98 each for aggregate gross proceeds of around $3 million.

The company said it will use an amount equal to the aggregate gross proceeds from the sale of the FT shares to incur eligible "Canadian exploration expenses". Tranche 1 FT shares also qualify for the Ontario focused flow-through share tax credit.

Additionally, the company also announced that will add a second tranche of flow-through shares for combined aggregate gross proceeds of up to $5.39 million, in connection with its previously announced $3 million non-brokered private placement with strategic investors.

This non-brokered private placement will offer 3.5-million common shares priced at $0.85 each for aggregate gross proceeds for around $3 million and roughly 2-million flow-through shares at a price of $1.19 each for gross proceeds of up to $2.39 million.

The TSX Venture Exchange has conditionally approved the first tranche of the non-brokered private placement.

The company expects the first and second tranches of the non-brokered private placement to close on or about May 29 and June 6, respectively. The closing of the second tranche is also subject to approval from the TSX Venture Exchange.

Shares of the company were last seen down $0.08 at $1.21 on the TSX Venture Exchange

Price: 1.21, Change: -0.08, Percent Change: -6.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bitcoin Miner Hive Digital to Buy Paraguay Site From Bitfarms for $85M
Bitcoin Miner Hive Digital to Buy Paraguay Site From Bitfarms for $85M
Jan 28, 2025
Hive Digital Technologies ( HIVE ) agreed to buy a site in Paraguay from fellow bitcoin miner Bitfarms ( BITF ) for a total of $85 million including assumed obligations. The acquisition of the site in Yguazú, Paraguay will more than triple Hive's hashrate to 25 exahash per second (Eh/s) by September, Hive said Tuesday. It will pay a total...
Brazil government supports Gol-Azul merger to strengthen airline sector
Brazil government supports Gol-Azul merger to strengthen airline sector
Jan 28, 2025
SAO PAULO (Reuters) - A planned merger between Brazilian airlines Gol and Azul ( AZUL ) would strengthen the sector and prevent either company from failing, Brazil's ports and airports minister told Reuters, giving the potential move a key government nod. Azul ( AZUL ) and Abra, the majority investor of Gol and Colombia's Avianca, announced earlier this month they...
Lundin Mining Warns of $46 Million Negative Impact on Q4 2024 Revenue
Lundin Mining Warns of $46 Million Negative Impact on Q4 2024 Revenue
Jan 28, 2025
06:44 AM EST, 01/28/2025 (MT Newswires) -- Lundin Mining ( LUNMF ) late on Monday said it expects a pre-tax negative impact of $46 million on its fourth-quarter 2024 revenue due to unaudited provisional pricing adjustments on prior period concentrate sales. The negative impact is mainly due to downward adjustments in relation to copper sales that are partially offset by...
BriaCell Therapeutics Completes 15:1 Share Consolidation
BriaCell Therapeutics Completes 15:1 Share Consolidation
Jan 28, 2025
06:41 AM EST, 01/28/2025 (MT Newswires) -- BriaCell Therapeutics Corp. ( BCTX ) , a clinical-stage biotechnology company, overnight Monday said it had completed a share consolidation of the company's issued and outstanding common shares on the basis of one post-consolidation common share for every fifteen pre-consolidation common shares. It said the consolidation is being implemented to ensure that the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved